BAMS
CLVS

Bellevue Asset Management (Switzerland)’s Clovis Oncology, Inc. CLVS Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$1.84M Sell
52,500
-2,500
-5% -$161K 0.28% 87
2015
Q3 		$5.06M Sell
55,000
-100
-0.2% -$8.65K 0.83% 44
2015
Q2 		$4.84M Buy
55,100
+13,000
+31% +$1.11M 0.67% 54
2015
Q1 		$3.13M Buy
+42,100
New +$2.97M 0.44% 64

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s CLVS Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) reduced its Clovis Oncology, Inc. (CLVS) stake by 4.5% in Q4 2015, selling an estimated $161K and leaving 52,500 shares worth $1.84M. The position accounts for 0.28% of the portfolio, ranked #87.

Bellevue Asset Management (Switzerland) first reported a position in CLVS in Q1 2015 and has held it in 4 quarters since. The position peaked at $5.06M in Q3 2015. 157 funds tracked by Wall St. Rank hold CLVS as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 52,500 shares of Clovis Oncology, Inc. worth $1.84M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) sold 2,500 Clovis Oncology, Inc. shares in Q4 2015, an estimated $161K.
  • Clovis Oncology, Inc. made up 0.28% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #87 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Clovis Oncology, Inc. in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Clovis Oncology, Inc. position peaked at $5.06M in Q3 2015.
  • 157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.